{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:09:46Z","timestamp":1772172586842,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007620","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000}}],"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007620","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T14:06:59Z","timestamp":1595513219000},"page":"e1007620","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2328-2018","authenticated-orcid":true,"given":"Jennifer L.","family":"Wilson","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-3599","authenticated-orcid":true,"given":"Dan","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Nick","family":"Corr","sequence":"additional","affiliation":[]},{"given":"Aaron","family":"Fullerton","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-5607","authenticated-orcid":true,"given":"James","family":"Lu","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"5","key":"pcbi.1007620.ref001","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0897190014546108","article-title":"Antineoplastic Agents and the Associated Myelosuppressive Effects: A Review","volume":"27","author":"JN Barreto","year":"2014","journal-title":"Journal of Pharmacy Practice"},{"issue":"2","key":"pcbi.1007620.ref002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01893697-200119020-00038","article-title":"Cancer-related fatigue: guidelines for evaluation and management","volume":"19","author":"RK Portenoy","year":"2001","journal-title":"Rehabilitation Oncology"},{"issue":"5","key":"pcbi.1007620.ref003","first-page":"293","article-title":"Towards Quantitative Systems Pharmacology Models of Chemotherapy\u2010Induced Neutropenia","volume":"6","author":"M Craig","year":"2017","journal-title":"CPT: pharmacomet syst pharmacol"},{"issue":"2","key":"pcbi.1007620.ref004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"GP Bodey","year":"1966","journal-title":"Ann Intern Med."},{"issue":"1","key":"pcbi.1007620.ref005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.7","article-title":"Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities","volume":"97","author":"K Venkatakrishnan","year":"2015","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"6","key":"pcbi.1007620.ref006","first-page":"357","article-title":"Translational Modeling of Drug\u2010Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor","volume":"6","author":"TA Collins","year":"2017","journal-title":"CPT: pharmacomet syst pharmacol"},{"key":"pcbi.1007620.ref007","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/toxsci\/kfg188","article-title":"Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics","volume":"75","author":"A Pessina","year":"2003","journal-title":"Toxicological Sciences"},{"issue":"24","key":"pcbi.1007620.ref008","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1200\/JCO.2002.02.140","article-title":"Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs","volume":"20","author":"LE Friberg","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"pcbi.1007620.ref009","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s11095-014-1429-9","article-title":"Characterization of Endogenous G-CSF and the Inverse Correlation to Chemotherapy-Induced Neutropenia in Patients with Breast Cancer Using Population Modeling","volume":"31","author":"AL Quartino","year":"2014","journal-title":"Pharm Res"},{"key":"pcbi.1007620.ref010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1200\/JCO.2017.35.15_suppl.1053","article-title":"Palbociclib exposure-response analyses in second-line treatment of hormone-receptor positive advanced breast cancer (ABC)","volume":"35","author":"W Sun","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"pcbi.1007620.ref011","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/cpt.1080","article-title":"Understanding Hematological Toxicities Using Mathematical Modeling","volume":"104","author":"C Fornari","year":"2018","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"11","key":"pcbi.1007620.ref012","first-page":"psp4.12459","article-title":"Quantifying drug\u2010induced bone marrow toxicity using a novel haematopoiesis systems pharmacology model","volume":"8","author":"C Fornari","year":"2019","journal-title":"CPT: pharmacomet syst pharmacol"},{"issue":"3","key":"pcbi.1007620.ref013","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vascn.2006.02.014","article-title":"Cell-based assays for profiling activity and safety properties of cancer drugs","volume":"54","author":"W Li","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"pcbi.1007620.ref014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1124\/jpet.115.223776","article-title":"Semimechanistic cell-cycle type-based pharmacokinetic\/pharmacodynamic model of chemotherapy-induced neutropenic effects of diflomotecan under different dosing schedules","volume":"354","author":"V Mangas-Sanjuan","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"pcbi.1007620.ref015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1535-7163.MCT-05-0130","article-title":"Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells","volume":"4","author":"DL Morse","year":"2005","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"pcbi.1007620.ref016","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"BA Weaver","year":"2014","journal-title":"MBoC"},{"issue":"12","key":"pcbi.1007620.ref017","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-17-1365","article-title":"T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors","volume":"24","author":"J Hu","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"5","key":"pcbi.1007620.ref018","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"P Mauch","year":"1995","journal-title":"Int J of Radiat Oncol Biol Phys"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007620","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T17:16:49Z","timestamp":1596561409000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007620"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007620","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2019.12.23.886960","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]}}}